• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂质平台可增强STING激动剂的活性,从而协同检查点阻断疗法治疗黑色素瘤。

The lipid platform increases the activity of STING agonists to synergize checkpoint blockade therapy against melanoma.

作者信息

Li Kesang, Ye Yingyi, Liu Liqin, Sha Qian, Wang Xiaolu, Jiao Ting, Zhang Li, Wang Jinyan

机构信息

Department of Hematology and Oncology, Hwa Mei Hospital, University of Chinese Academy of Sciences, Zhejiang Province, Ningbo 315000, China.

出版信息

Biomater Sci. 2021 Feb 7;9(3):765-773. doi: 10.1039/d0bm00870b. Epub 2020 Nov 17.

DOI:10.1039/d0bm00870b
PMID:33201161
Abstract

The response rate to PD-1/PD-L1 immune checkpoint inhibition (ICI) therapy in melanoma remains low due to the immunosuppressive tumor microenvironment. Novel strategies synergizing ICI treatment are urgently sought after. Activation of the stimulator of interferon genes (STING) has recently emerged as a critical pathway to overcome immunosuppression. Herein, 2'3' cyclic guanosine monophosphate-adenosine monophosphate (cGAMP), a universal STING agonist, was encapsulated into lipid nanoparticles conjugated with mannose (LP-cGAMP) for dendritic cell (DC)-specific cytosolic delivery. LP-cGAMP induced STING-related pro-inflammatory and intratumoral injections of LP-cGAMP increased DC maturation and CD8 T cell infiltration more efficiently compared to free cGAMP. Given the upregulation of PD-L1 on tumor cells in response to STING activation, we further tested the combination therapy of LP-cGAMP and anti-PD-L1 and observed a superior antitumor effect in B16F10 and BRAF-mutated murine melanoma models. Our findings prove that targeted delivery of cGAMP can synergize PD-L1 blockade therapy in melanoma and the combinational immune therapy has a great potential to produce a long-lasting anti-tumor effect.

摘要

由于免疫抑制性肿瘤微环境,黑色素瘤对PD-1/PD-L1免疫检查点抑制(ICI)疗法的反应率仍然很低。迫切需要新的策略来协同ICI治疗。干扰素基因刺激物(STING)的激活最近已成为克服免疫抑制的关键途径。在此,2'3'环磷酸鸟苷-磷酸腺苷(cGAMP),一种通用的STING激动剂,被封装到与甘露糖偶联的脂质纳米颗粒(LP-cGAMP)中,用于树突状细胞(DC)特异性胞质递送。与游离cGAMP相比,LP-cGAMP诱导的与STING相关的促炎反应和瘤内注射LP-cGAMP能更有效地促进DC成熟和CD8 T细胞浸润。鉴于肿瘤细胞上PD-L1的上调是对STING激活的反应,我们进一步测试了LP-cGAMP和抗PD-L1的联合疗法,并在B16F10和BRAF突变的小鼠黑色素瘤模型中观察到了卓越的抗肿瘤效果。我们的研究结果证明,cGAMP的靶向递送可以协同黑色素瘤中的PD-L1阻断疗法,并且联合免疫疗法具有产生持久抗肿瘤效果的巨大潜力。

相似文献

1
The lipid platform increases the activity of STING agonists to synergize checkpoint blockade therapy against melanoma.脂质平台可增强STING激动剂的活性,从而协同检查点阻断疗法治疗黑色素瘤。
Biomater Sci. 2021 Feb 7;9(3):765-773. doi: 10.1039/d0bm00870b. Epub 2020 Nov 17.
2
Nanoparticle delivery improves the pharmacokinetic properties of cyclic dinucleotide STING agonists to open a therapeutic window for intravenous administration.纳米颗粒递呈改善环状二核苷酸 STING 激动剂的药代动力学特性,为静脉给药开辟治疗窗口。
J Control Release. 2021 Feb 10;330:1118-1129. doi: 10.1016/j.jconrel.2020.11.017. Epub 2020 Nov 12.
3
A nanoparticle-incorporated STING activator enhances antitumor immunity in PD-L1-insensitive models of triple-negative breast cancer.一种纳米颗粒结合的 STING 激活剂增强了 PD-L1 不敏感的三阴性乳腺癌模型中的抗肿瘤免疫。
JCI Insight. 2018 Nov 15;3(22):120638. doi: 10.1172/jci.insight.120638.
4
Potent STING activation stimulates immunogenic cell death to enhance antitumor immunity in neuroblastoma.强效 STING 激活可刺激免疫原性细胞死亡,增强神经母细胞瘤中的抗肿瘤免疫。
J Immunother Cancer. 2020 Mar;8(1). doi: 10.1136/jitc-2019-000282.
5
Delivery of a STING Agonist Using Lipid Nanoparticles Inhibits Pancreatic Cancer Growth.脂质纳米颗粒递送 STING 激动剂抑制胰腺癌生长。
Int J Nanomedicine. 2024 Aug 27;19:8769-8778. doi: 10.2147/IJN.S462213. eCollection 2024.
6
Antitumor effect of anti-vascular therapy with STING agonist depends on the tumor microenvironment context.使用STING激动剂进行抗血管治疗的抗肿瘤效果取决于肿瘤微环境背景。
Front Oncol. 2023 Aug 15;13:1249524. doi: 10.3389/fonc.2023.1249524. eCollection 2023.
7
STING agonist loaded lipid nanoparticles overcome anti-PD-1 resistance in melanoma lung metastasis via NK cell activation.STING 激动剂负载的脂质纳米颗粒通过 NK 细胞激活克服黑色素瘤肺转移中的抗 PD-1 耐药性。
J Immunother Cancer. 2021 Jul;9(7). doi: 10.1136/jitc-2021-002852.
8
Zebularine elevates STING expression and enhances cGAMP cancer immunotherapy in mice.噻唑并咔唑提升 STING 表达并增强 cGAMP 癌症免疫疗法在小鼠中的效果。
Mol Ther. 2021 May 5;29(5):1758-1771. doi: 10.1016/j.ymthe.2021.02.005. Epub 2021 Feb 9.
9
STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity.肿瘤内皮细胞的STING激活引发自发和治疗性抗肿瘤免疫。
Proc Natl Acad Sci U S A. 2015 Dec 15;112(50):15408-13. doi: 10.1073/pnas.1512832112. Epub 2015 Nov 25.
10
A 2D Nanoradiosensitizer Enhances Radiotherapy and Delivers STING Agonists to Potentiate Cancer Immunotherapy.二维纳米增敏剂增强放射治疗并递送 STING 激动剂以增强癌症免疫治疗。
Adv Mater. 2022 Sep;34(39):e2110588. doi: 10.1002/adma.202110588. Epub 2022 Aug 26.

引用本文的文献

1
Immune Responses of Dendritic Cells to Zoonotic DNA and RNA Viruses.树突状细胞对人畜共患DNA和RNA病毒的免疫反应
Vet Sci. 2025 Jul 24;12(8):692. doi: 10.3390/vetsci12080692.
2
Potentiating cancer immunotherapies with modular albumin-hitchhiking nanobody-STING agonist conjugates.利用模块化白蛋白搭载纳米抗体-STING激动剂偶联物增强癌症免疫疗法。
Nat Biomed Eng. 2025 Jun 11. doi: 10.1038/s41551-025-01400-0.
3
Targeted STING Activation Using Modified Ultrasound-Responsive Microbubbles Enhances Immune Checkpoint Blockade Against Melanoma.
使用改良的超声响应微泡靶向激活STING增强对黑色素瘤的免疫检查点阻断作用
Adv Sci (Weinh). 2025 Jun;12(22):e2416596. doi: 10.1002/advs.202416596. Epub 2025 Mar 26.
4
Targeting cGAS-STING pathway for reprogramming tumor-associated macrophages to enhance anti-tumor immunotherapy.靶向环鸟苷酸-腺苷酸合成酶-干扰素基因刺激蛋白(cGAS-STING)通路重编程肿瘤相关巨噬细胞以增强抗肿瘤免疫治疗
Biomark Res. 2025 Mar 12;13(1):43. doi: 10.1186/s40364-025-00750-w.
5
Nanocarrier-mediated modulation of cGAS-STING signaling pathway to disrupt tumor microenvironment.纳米载体介导的cGAS-STING信号通路调节以破坏肿瘤微环境
Naunyn Schmiedebergs Arch Pharmacol. 2025 Feb 5. doi: 10.1007/s00210-025-03835-3.
6
Delivery of a STING Agonist Using Lipid Nanoparticles Inhibits Pancreatic Cancer Growth.脂质纳米颗粒递送 STING 激动剂抑制胰腺癌生长。
Int J Nanomedicine. 2024 Aug 27;19:8769-8778. doi: 10.2147/IJN.S462213. eCollection 2024.
7
Programable Albumin-Hitchhiking Nanobodies Enhance the Delivery of STING Agonists to Potentiate Cancer Immunotherapy.可编程白蛋白搭载纳米抗体增强STING激动剂的递送以增强癌症免疫治疗
Res Sq. 2024 May 8:rs.3.rs-3243545. doi: 10.21203/rs.3.rs-3243545/v1.
8
Nanomaterial-encapsulated STING agonists for immune modulation in cancer therapy.用于癌症治疗中免疫调节的纳米材料封装的STING激动剂。
Biomark Res. 2024 Jan 7;12(1):2. doi: 10.1186/s40364-023-00551-z.
9
Overcoming challenges in the delivery of STING agonists for cancer immunotherapy: A comprehensive review of strategies and future perspectives.克服癌症免疫治疗中STING激动剂递送的挑战:策略与未来展望的全面综述
Mater Today Bio. 2023 Oct 21;23:100839. doi: 10.1016/j.mtbio.2023.100839. eCollection 2023 Dec.
10
Lipid-based nanoparticles as drug delivery systems for cancer immunotherapy.基于脂质的纳米颗粒作为癌症免疫治疗的药物递送系统。
MedComm (2020). 2023 Aug 7;4(4):e339. doi: 10.1002/mco2.339. eCollection 2023 Aug.